It has been shown that urinary excretion of TRAIL positively correlates with response to BCG in humans, with TRAIL demonstrating direct cytotoxicity of bladder tumor cells in vitro (51). The gene discussed is TNFSF10; the disease is urinary bladder neoplasm.